In this episode, Dr. Orna Dreazen, chairperson of Nextage Cannabis Innovations and Nextar ChemPharma Solutions tells us about breakthrough developments coming out of Nextage.

Nextage has developed nanotechnology that enables the penetration of various drugs, including cannabinoids, into the blood brain barrier, exhibiting both safety and efficacy.

Dr. Dreazen also describes exciting developments with some of the rare cannabinoids such as CBN.

Investors, as well as potential licensing partners, are welcome to reach out to Dr. Dreazen at

Nextage Cannabis Innovation Center https://nextageinnovation.com/

Nextar ChemPharma Solutions https://www.nextar.co.il/